Mausner-Fainberg K - Search Results

1

Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.

Urshansky N, Mausner-Fainberg K, Auriel E, Regev K, Farhum F, Karni A. Urshansky N, et al. J Neurol Sci. 2010 Aug 15;295(1-2):31-7. doi: 10.1016/j.jns.2010.05.019. Epub 2010 Jun 11. J Neurol Sci. 2010. PMID: 20541775

2

Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.

Urshansky N, Mausner-Fainberg K, Auriel E, Regev K, Bornstein NM, Karni A. Urshansky N, et al. J Neuroimmunol. 2011 Mar;232(1-2):171-8. doi: 10.1016/j.jneuroim.2010.10.007. Epub 2010 Nov 26. J Neuroimmunol. 2011. PMID: 21111488

3

Low and dysregulated production of follistatin in immune cells of relapsing-remitting multiple sclerosis patients.

Urshansky N, Mausner-Fainberg K, Auriel E, Regev K, Karni A. Urshansky N, et al. J Neuroimmunol. 2011 Sep 15;238(1-2):96-103. doi: 10.1016/j.jneuroim.2011.08.003. Epub 2011 Aug 31. J Neuroimmunol. 2011. PMID: 21880375

4

Elevated and dysregulated bone morphogenic proteins in immune cells of patients with relapsing-remitting multiple sclerosis.

Mausner-Fainberg K, Urshansky N, Regev K, Auriel E, Karni A. Mausner-Fainberg K, et al. J Neuroimmunol. 2013 Nov 15;264(1-2):91-9. doi: 10.1016/j.jneuroim.2013.09.004. Epub 2013 Sep 18. J Neuroimmunol. 2013. PMID: 24080309

5

Dysregulated production of leukemia inhibitory factor in immune cells of relapsing remitting multiple sclerosis patients.

Levy YA, Mausner-Fainberg K, Vaknin-Dembinsky A, Amidror T, Regev K, Karni A. Levy YA, et al. J Neuroimmunol. 2015 Jan 15;278:85-9. doi: 10.1016/j.jneuroim.2014.12.010. Epub 2014 Dec 10. J Neuroimmunol. 2015. PMID: 25595256

6

Increased neutralization capacity of TNF-α in sera of relapsing remitting multiple sclerosis patients is not related to soluble TNF-α receptors or anti-TNF-α autoantibody levels.

Mausner-Fainberg K, Regev K, Kolb H, Vaknin-Dembinsky A, Karni A. Mausner-Fainberg K, et al. J Neuroimmunol. 2015 Sep 15;286:83-5. doi: 10.1016/j.jneuroim.2015.07.005. Epub 2015 Jul 17. J Neuroimmunol. 2015. PMID: 26298329

7

High serum levels of BMP-2 correlate with BMP-4 and BMP-5 levels and induce reduced neuronal phenotype in patients with relapsing-remitting multiple sclerosis.

Penn M, Mausner-Fainberg K, Golan M, Karni A. Penn M, et al. Among authors: mausner fainberg k. J Neuroimmunol. 2017 Sep 15;310:120-128. doi: 10.1016/j.jneuroim.2017.07.008. Epub 2017 Jul 15. J Neuroimmunol. 2017. PMID: 28778435

8

Fingolimod Increases Brain-Derived Neurotrophic Factor Level Secretion from Circulating T Cells of Patients with Multiple Sclerosis.

Golan M, Mausner-Fainberg K, Ibrahim B, Benhamou M, Wilf-Yarkoni A, Kolb H, Regev K, Karni A. Golan M, et al. Among authors: mausner fainberg k. CNS Drugs. 2019 Dec;33(12):1229-1237. doi: 10.1007/s40263-019-00675-7. CNS Drugs. 2019. PMID: 31713782

9

Increased Expression of Ephrins on Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis Affects Oligodendrocyte Differentiation.

Golan M, Krivitsky A, Mausner-Fainberg K, Benhamou M, Vigiser I, Regev K, Kolb H, Karni A. Golan M, et al. Among authors: mausner fainberg k. Int J Mol Sci. 2021 Feb 22;22(4):2182. doi: 10.3390/ijms22042182. Int J Mol Sci. 2021. PMID: 33671716 Free PMC article.

10

Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.

Azoulay D, Mausner-Fainberg K, Urshansky N, Fahoum F, Karni A. Azoulay D, et al. J Neuroimmunol. 2009 Jun 25;211(1-2):114-9. doi: 10.1016/j.jneuroim.2009.04.004. Epub 2009 May 5. J Neuroimmunol. 2009. PMID: 19419774

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters